학술논문

Acyclovir plus CMV immunoglobulin prophylaxis and early therapy with ganciclovir are effective and safe in CMV high-risk renal transplant pediatric recipients
Document Type
Article
Source
In: Transplant International. (Transplant International, 1998, 11(SUPPL. 1):S130-S134)
Subject
Language
English
ISSN
09340874